Joel P. Freiman, MD, MPH is a doctor of internal medicine and pharmacoepidemiologist with 10 years of experience at the Food and Drug Administration (FDA).

Dr. Freiman received his medical degree from New York Medical College in 1981, became a Diplomate of the American Board of Internal Medicine and was Board Certified in Internal Medicine in 1984. He continued his postgraduate career at the University of Texas School of Public Health, where he received his Masters degree in Public Health in 1989.

He served in the capacities of Staff Fellow, Medical Officer and Branch Chief of Epidemiology within FDA’s Center for Drug Evaluation and Research. During Dr. Freiman's first eight years at FDA, he provided epidemiologic assessments on numerous complex drug safety issues. During his last two years at FDA Dr. Freiman served as a Medical Officer, in the Division of Neuropsychiatric Drug Products, Center for Drug Evaluation and Research, where he reviewed and evaluated clinical trial data for safety and effectiveness.

Prior to joining the FDA, Dr. Freiman was an Assistant Professor of Medicine in the Department of Internal Medicine at Baylor College of Medicine in Houston, Texas and later served as an Attending Physician in Internal Medicine on the Acute Care Medical Service at the Veteran's Administration Hospital in West Palm Beach, FL. At the VA, Dr. Freiman Chaired the Preventative Medicine Committee from 1995-1997.

After leaving the FDA in 2000, he worked for eight years as an independent consultant to the pharmaceutical industry reviewing and analyzing adverse event data and providing expert testimony re: safety of certain pharmaceutical agents. Dr. Freiman then joined Lexicon Pharmaceuticals as a Senior Medical Director of Drug Safety providing comprehensive safety surveillance for all the company’s development programs.

Dr. Freiman received the Food and Drug Administration Commendable Service Award in 1994 and the West Palm Beach VAMC Supervisory Physician of the Year Award in 1997. He has numerous scientific publications and peer-reviewed articles, and has offered seminars on pharmacoepidemiology and lectured extensively in his area of expertise across the country. Dr. Freiman's research interest is to understand the predictive and mechanistic factors of adverse drug reactions.